98%
921
2 minutes
20
The documentation, preservation and rescue of biological diversity increasingly uses living biological samples. Persistent associations between species, biosamples, such as tissues and cell lines, and the accompanying data are indispensable for using, exchanging and benefiting from these valuable materials. Explicit authentication of such biosamples by assigning unique and robust identifiers is therefore required to allow for unambiguous referencing, avoid identification conflicts and maintain reproducibility in research. A predefined nomenclature based on uniform rules would facilitate this process. However, such a nomenclature is currently lacking for animal biological material. We here present a first, standardized, human-readable nomenclature design, which is sufficient to generate unique and stable identifying names for animal cellular material with a focus on wildlife species. A species-specific human- and machine-readable syntax is included in the proposed standard naming scheme, allowing for the traceability of donated material and cultured cells, as well as data FAIRification. Only when it is consistently applied in the public domain, as publications and inter-institutional samples and data are exchanged, distributed and stored centrally, can the risks of misidentification and loss of traceability be mitigated. This innovative globally applicable identification system provides a standard for a sustainable structure for the long-term storage of animal bio-samples in cryobanks and hence facilitates current as well as future species conservation and biomedical research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11171381 | PMC |
http://dx.doi.org/10.3390/ani14111541 | DOI Listing |
Front Psychiatry
August 2025
TransLab Research Group, Department of Medical Sciences, University of Girona, Girona, Spain.
Introduction: Clinical practice guidelines (CPGs) have several limitations, namely: obsolescence, lack of personalization, and insufficient patient participation. These factors may contribute to suboptimal treatment recommendation compliance and poorer clinical outcomes. APPRAISE-RS is an adaptation of the GRADE heuristic designed to generate CPG-like treatment recommendations that are automated, updated, personalized, participatory, and explanatory using a symbolic AI approach.
View Article and Find Full Text PDFArXiv
August 2025
Nationwide Children's Hospital, Columbus, OH.
In 2024, individuals funded by NHGRI to support genomic community resources completed a Self-Assessment Tool (SAT) to evaluate their application of the FAIR (Findable, Accessible, Interoperable, and Reusable) principles and assess their sustainability. By collecting insights from the self-administered questionnaires and conducting personal interviews, a valuable perspective was gained on the FAIRness and sustainability of the NHGRI resources. The results highlighted several challenges and key areas the NHGRI resource community could improve by working together to form recommendations to address these challenges.
View Article and Find Full Text PDFCancer Treat Rev
August 2025
Department of Oncology, University Hospital CHUV, Lausanne, Switzerland.
Immunogenicity of a therapeutic protein product may elicit an unintended immune response, and is a critical aspect evaluated in oncology clinical trials. The development of anti-drug antibodies (ADAs) can impact the pharmacokinetics, pharmacodynamics, efficacy, and safety of these therapies. We review the background and nomenclature of immunogenicity assessment in oncology studies and emphasize the complexities in ADA detection arising from assay sensitivity, drug interference, and notably, the frequency of patient sampling for ADA analysis.
View Article and Find Full Text PDFBMC Cancer
August 2025
Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Background And Purpose: Angiosarcoma (AS), a rare and highly malignant tumour, can manifest spontaneously (primary AS, pAS) or secondary to previous radiation, exposure to chemical agents or Stewart-Treves syndrome (secondary AS, sAS). The aim of this study was to characterise the clinical presentation, management, treatment and outcome-including local recurrence, metastasis and overall survival-among patients diagnosed with AS and treated at Sahlgrenska University Hospital, Gothenburg, Sweden.
Study Methods And Design: This is a retrospective single-centre study analysing patients treated for AS at Sahlgrenska University Hospital.
Facial Plast Surg Aesthet Med
August 2025
Facial Plastic & Reconstructive Surgery, Facial Paralysis Institute, Beverly Hills, California, USA.
Variable terminology is used in the literature to describe facial synkinesis and hypertonicity following incomplete recovery from facial paralysis and its associated medical and surgical treatments. Establish a nomenclature consensus for this condition among a group of facial nerve experts. Consensus study.
View Article and Find Full Text PDF